Aimovig 140 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FXRM5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,966
Award facts
- Contract value 100% obligated
- $19,965.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,965.59 to AmerisourceBergen Drug Corp for the supply of Aimovig 140 mg/ml auto-injectors. This competitively awarded, firm fixed-price delivery order was finalized on December 22, 2025, with an ultimate completion date of December 23, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare systems globally.
Aimovig is a migraine treatment medication administered via auto-injector, representing one of many specialty pharmaceutical products within AmerisourceBergen's extensive federal contract portfolio. As a major pharmaceutical distributor serving military and veteran healthcare systems, AmerisourceBergen maintains a demonstrated capability to fulfill federal medical procurement requirements through open competition across diverse therapeutic domains. The DLA Troop Support Medical contract vehicle provides significant flexibility for the agency to procure critical medical commodities, including specialty medications, brand-name and generic drugs, and related medical supplies needed to support Defense Health Agency operations and broader federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FXRM5?
SPE2DR26FXRM5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FXRM5 worth?
The government has obligated $19,966 on SPE2DR26FXRM5.
Is contract SPE2DR26FXRM5 an order under another contract?
Yes. SPE2DR26FXRM5 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXRM5 competed?
The extent of competition for SPE2DR26FXRM5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award